Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Antiviral Activity of Probiotics in the Prophylaxis and Therapy of Respiratory Infections Associated with Coronavirus (COVID-19): Meta-Analysis of Randomized Controlled Trials
*Corresponding Author: Slimane Chawki Mokadem, Department of Biology, University centre Nour Bachir of El-Bayadh, 32000 El-Bayadh, Algeria, Email: chawki.mokadem98@gmail.comReceived Date: Jun 12, 2024 / Published Date: Jul 15, 2024
Citation: Mokadem SC, Naimi M, Alami O (2024) Antiviral Activity of Probiotics in the Prophylaxis and Therapy of Respiratory Infections Associated with Coronavirus (COVID-19): Meta analysis of Randomized Controlled Trials. J Infect Dis Ther S7:004.DOI: 10.4173/2332-0877.24.S7.004
Copyright: © 2024 Mokadem SC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction: Probiotics, living microorganisms administered in sufficient quantities, exert beneficial effects on host health. Given the high prevalence of SARS-CoV-2, recent studies suggest potential positive impacts of probiotics on COVID-19 patients.
Methods: A predetermined search strategy encompassing seven databases: NCBI, PubMed, Science Direct, Springer Link, Embase, CNKI, and Cochrane Library Databases, was implemented. Human RCTs studies were scrutinized independently, involving data extraction, quality and risk of bias assessment, and statistical analysis. Pooled data, employing the random-effects model were expressed as Standardized Mean Differences (SMD) with a 95% Confidence Interval (CI). Assessments of (p) value and heterogeneity (I²) were conducted and quantified.
Results: Five studies, comprising 282 out of 375 participants, were included. Meta-analysis revealed effects on various parameters: CRP (SMD=0.26 MG/L, 95% CI (0.10, 0.43), p=0.002, (I2=67%, p=0.03)), BMI (SMD=0.28 KG/m², 95% CI (0.07, 0.50), p=0.01, (I2=67%, p=0.40)), T-cells (SMD=0.09 G/L, 95% CI (-0.07, 0.26), p=0.26, (I²=0%,p=0.73)), Albumin (SMD=0.28 G/DL, 95% CI (0.04, 0.52), p=0.02, (I²=7%, p=0.34)), IL-6 (SMD=0.67, 95% CI (0.45, 0.90), p=0.00001, (I²=94%, p=0.0001)), LDH (SMD=0.12 mmol/L, 95% CI (-0.05, 0.30), p=0.17, (I²=55%, p=0.13)), and Ferritin (SMD=0.19 mmol/L, 95% CI (-0.27, 0.66), p=0.41, (I²=77%, p=0.04)).
Conclusion: This meta-analysis suggests significant positive effects of probiotics on various measures for COVID-19 treatment.
